Clinical and Radiological Outcomes Following Insertion of a Novel Removable Percutaneous Interspinous Process Spacer: an Initial Experience.
LOBSTER
A Multicentric Retrospective Evaluation of Clinical and Radiologic Outcome of All Patients Treated With a Removable Percutaneous Interspinous Process Spacer (LobsterProject® Techlamed®) for Symptomatic Degenerative Lumbar Spinal Stenosis in 2019.
1 other identifier
observational
59
1 country
1
Brief Summary
Purpose To evaluate clinical and radiologic outcome of a series of patients treated with a removable percutaneous interspinous process spacer (IPS) (LobsterProject® Techlamed®) for symptomatic degenerative lumbar spinal stenosis (DLSS). Methods All patients treated in the two considered Centres with this IPS during 2019 were retrospectively reviewed. Patients with incomplete clinical or radiological documentation were not included. Procedures were performed under deep sedation or general anaesthesia by two interventional radiologists. Patients were clinically evaluated before intervention and at 3-month follow-up with Visual Analog Scale for pain (VAS), Oswestry Disability Index (ODI) and radiologically with MRI or CT scans. Neural foramina were independently measured for each patient on pre- and post-procedural CT scans by two radiologists.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2021
CompletedFirst Submitted
Initial submission to the registry
December 27, 2021
CompletedFirst Posted
Study publicly available on registry
January 24, 2022
CompletedJanuary 24, 2022
December 1, 2021
5 months
December 27, 2021
January 21, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Oswestry Disability Index
Disability level evaluated with Oswestry Disability Index before intervention
Baseline
Oswestry Disability Index
Disability level evaluated with Oswestry Disability Index after intervention
3 Months
Secondary Outcomes (4)
Visual Analog Scale for pain
Baseline
Visual Analog Scale for pain
3 Months
Variation of foraminal area
Baseline
Variation of foraminal area
3 Months
Study Arms (1)
degenerative lumbar spinal stenosis
All patients treated in 2019 with a percutaneous removable interspinous process spacer a neurologic intermittent clauditation due to a degenerative lumbar spinal stenosis.
Interventions
percutaneous removable interspinous process spacer a neurologic intermittent clauditation due to a degenerative lumbar spinal stenosis.
Eligibility Criteria
All patients treated with this removable percutaneous IPS in our two Centres from December 2018 to February 2020 were retrospectively reviewed and those with complete imaging and clinical data were selected. Patients attended interventional radiology outpatient consultations for back pain and NIC, refractory to medical treatment.
You may qualify if:
- removable percutaneous IPS treatment
- attended interventional radiology outpatient consultations for back pain and NIC, refractory to medical treatment
You may not qualify if:
- PS positioning included cauda equina syndrome
- permanent motor deficit,
- previous spine surgery,
- spondylolisthesis greater than Meyerding grade I,
- local or systemic infection and severe osteoarthritis with pronounced osteophytosis or bone bridges
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nice University Hospital
Nice, 06000, France
Related Publications (1)
Pavan LJ, Dalili D, De Vivo AE, Hamel-Senecal A, Torre F, Rudel A, Manfre L, Amoretti N. Clinical and radiological outcomes following insertion of a novel removable percutaneous interspinous process spacer: an initial experience. Neuroradiology. 2022 Sep;64(9):1887-1895. doi: 10.1007/s00234-022-02977-y. Epub 2022 May 31.
PMID: 35641830DERIVED
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 27, 2021
First Posted
January 24, 2022
Study Start
January 1, 2021
Primary Completion
June 1, 2021
Study Completion
October 21, 2021
Last Updated
January 24, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share